2026 Annual Meeting | C25 - Basic Science: Neuropathology

��ɫ��

2026 Annual Meeting | C25 - Basic Science: Neuropathology

Date Saturday 04/18/26

Time 12:00 PM - 04:30 PM CDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Half-Day Course

Director(s) Ashley Holloman, MD

Topic(s) ��ɫ��, Research, and Methodology

Learning Objectives Participants should be able to recognize common gross, histological, and molecular features of central nervous system disorders, and be able to understand cellular and gross neuropathology in relationship to neurologic disease mechanisms, diagnosis, laboratory studies, imaging, and progression of disease.

CME Available 4.50 CME credits

Core Competencies Patient Care & Procedural Skills, Practice-based Learning and Improvement

Program Level Introductory

Program Tracks Advanced Practice Provider

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic

Event Timeline
12:00 PM - 12:05 PM CDT	Introduction	Introduction Ashley Holloman, MD
12:05 PM - 01:05 PM CDT	Speaker	Tumors & Infectious Disease Ashley Holloman, MD
01:05 PM - 02:05 PM CDT	Speaker	Neurodegenerative Disease & Cerebrovascular Disorders Oluwaseun Ogunbona, MD, PhD
02:05 PM - 02:15 PM CDT	Break	Break
02:15 PM - 03:15 PM CDT	Speaker	Neurodevelopmental Disorders & Skeletal Muscle Carrie Mohila, MD, PhD
03:15 PM - 04:15 PM CDT	Speaker	Demyelinating Disease & Toxic/Metabolic Disorders Ashley Holloman, MD
04:15 PM - 04:30 PM CDT	Q&A	Questions and Answers Ashley Holloman, MD

Faculty Disclosures
Ashley Holloman, MD	Dr. Holloman has nothing to disclose.
Carrie Mohila, MD, PhD	Dr. Mohila has stock in Johnson & Johnson. The institution of Dr. Mohila has received research support from NINDS. The institution of Dr. Mohila has received research support from National MS Society. The institution of Dr. Mohila has received research support from Diana Helis Foundation. The institution of Dr. Mohila has received research support from NINDS.
Oluwaseun Ogunbona, MD, PhD	Dr. Ogunbona has nothing to disclose.

��ɫ����

��ɫ����

��ɫ��

��ɫ��